JOURNAL ARTICLE

The potential of plasma exchange in treating Chronic Fatigue Syndrome and long COVID: Targeting autoimmune and inflammatory mechanisms.

  • Published In: Transfusion, 2025, v. 65, n. 3. P. 423 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Akgun, Yamac 3 of 3

Abstract

The article discusses the potential of therapeutic plasma exchange (TPE) in treating Chronic Fatigue Syndrome (CFS) and long COVID by targeting autoimmune and inflammatory mechanisms. Both conditions share symptoms such as fatigue, cognitive impairments, and autonomic dysfunction, with immune dysregulation and endothelial injury playing key roles. TPE shows promise in removing autoantibodies and pro-inflammatory cytokines, but further research is needed to standardize treatment protocols and assess long-term efficacy. The article emphasizes the importance of identifying ideal patient candidates and conducting randomized controlled trials to validate the role of TPE in managing these challenging syndromes. [Extracted from the article]

Additional Information

  • Source:Transfusion. 2025/03, Vol. 65, Issue 3, p423
  • Document Type:Article
  • Subject Area:Consumer Health
  • Publication Date:2025
  • ISSN:0041-1132
  • DOI:10.1111/trf.18099
  • Accession Number:183898024
  • Copyright Statement:Copyright of Transfusion is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.